Cargando…
Molecular subtype conversion in CTCs as indicator of treatment adequacy associated with metastasis-free survival in breast cancer
Molecular subtype of breast cancer has a great clinical significance and used as one of the major criteria for therapeutic strategy. Recently, for anticancer therapy, the trend for oncologists is the predominant determination of biomarkers in the existing foci of the disease. In the case of adjuvant...
Autores principales: | Grigoryeva, E. S., A.Tashireva, L., Alifanov, V. V., Savelieva, O. E., Vtorushin, S. V., Zavyalova, M. V., Bragina, O. D., Garbukov, E. Y., Cherdyntseva, N. V., Choinzonov, E. L., Perelmuter, V. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723174/ https://www.ncbi.nlm.nih.gov/pubmed/36470982 http://dx.doi.org/10.1038/s41598-022-25609-0 |
Ejemplares similares
-
The Novel Association of Early Apoptotic Circulating Tumor Cells with Treatment Outcomes in Breast Cancer Patients
por: Grigoryeva, Evgeniya S., et al.
Publicado: (2022) -
Heterogeneous Manifestations of Epithelial–Mesenchymal Plasticity of Circulating Tumor Cells in Breast Cancer Patients
por: Tashireva, Liubov A., et al.
Publicado: (2021) -
The Association of Integrins β3, β4, and αVβ5 on Exosomes, CTCs and Tumor Cells with Localization of Distant Metastasis in Breast Cancer Patients
por: Grigoryeva, Evgeniya S., et al.
Publicado: (2023) -
Mechanisms behind prometastatic changes induced by neoadjuvant chemotherapy in the breast cancer microenvironment
por: Perelmuter, Vladimir M, et al.
Publicado: (2019) -
Heterogeneity of Stemlike Circulating Tumor Cells in Invasive Breast Cancer
por: Savelieva, Olga E., et al.
Publicado: (2020)